PAA 2.50% 19.5¢ pharmaust limited

Ann: Resignation of Dr Richard Mollard, page-32

  1. 8,849 Posts.
    lightbulb Created with Sketch. 1712
    So Epichem CEO resigns in February and announcement states that Epichem has commenced an executive search for a General Manager and also a new business development executive.
    Epichem then hire a new head of chemistry, this appointment hidden in quarterly.
    We hear nothing in 3 months around the search for a new CEO
    May 16 it is reported tablets have arrived and second batch on route, however tablets have some minor impurities, that regulatory approval for mnd trial still not signed and that trial can not proceed until approval is signed.
    However heading states trial on track to commence in May.
    February 17 Announcement that a loan for $210k at 1.25%
    Feb 24 announcement paper work for mnd trial still pending, recruitment and recruitment now to start in June and covid trial delayed but will be a phrase 2.
    May 27 CSO / Pitney Pharma resignes
    Something not right
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $94.81M
Open High Low Value Volume
20.0¢ 20.0¢ 19.5¢ $156.9K 801.4K

Buyers (Bids)

No. Vol. Price($)
16 823726 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 347222 8
View Market Depth
Last trade - 15.53pm 01/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.